Dr. D'Souza is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9200 W Wisconsin Ave
Milwaukee, WI 53226Phone+1 414-805-4600Fax+1 414-805-6805
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 2010 - 2014
Corewell Health East Beaumont (Royal Oak)Residency, Internal Medicine, 2007 - 2010
Goa Medical CollegeClass of 1999
Certifications & Licensure
WI State Medical License 2013 - 2025
MN State Medical License 2010 - 2014- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Doxycycline to Upgrade Organ Response in Light Chain (AL) Amyloidosis Trial Start of enrollment: 2014 Oct 01
- Assessment of Allogeneic Hematopoietic Cell Transplantation in Medicare Beneficiaries With Multiple Myeloma Start of enrollment: 2017 Jul 25
- Daratumumab, Pomalidomide, and Dexamethasone (DPd) in Relapsed/Refractory Light Chain Amyloidosis Patients Previously Exposed to Daratumumab Start of enrollment: 2021 Apr 14
Publications & Presentations
PubMed
- 1 citationsGlobal characteristics and outcomes of autologous hematopoietic stem cell transplantation for newly diagnosed multiple myeloma: A study of the worldwide network for bl...Laurent Garderet, Luuk Gras, Linda Koster, Laurien Baaij, Nada Hamad
American Journal of Hematology. 2024-11-01 - 3 citationsA cross-sectional study of patient-reported outcomes and symptom burden using PROMIS and PRO-CTCAE measures in light chain amyloidosis.Anita D'Souza, Aniko Szabo, Idayat Akinola, Muriel Finkel, Kathryn E Flynn
Quality of Life Research. 2023-06-01 - 8 citationsPreclinical discovery and initial clinical data of WVT078, a BCMA × CD3 bispecific antibody.Marc S Raab, Yael C Cohen, Fredrik Schjesvold, Kimberly Aardalen, Adwait Oka
Leukemia. 2023-06-01
Abstracts/Posters
- Novel Prognostic Scoring System for Autologous Hematopoietic Cell Transplantation (AHCT) in Multiple Myeloma (MM)Anita D'Souza, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Breaking the Glass Ceiling of Age in Transplant in Multiple MyelomaAnita D'Souza, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Primary Plasma Cell Leukemia Outcomes Remain Dismal Despite Novel Agents and Hematopoietic Cell TransplantationAnita D'Souza, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Join now to see all
Press Mentions
No Survival Benefit with All-Oral Regimen for Relapsed/Refractory MyelomaJune 18th, 2021
Real-World Results Show Medicare Costs Drop After Completion of CAR T-cell TherapyDecember 7th, 2019
The Ethics of Pay-to-Play Trials; How Dementia Robs UsSeptember 28th, 2019- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
